Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy-Reference-Cited by-同舟云学术

Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy

Published:2022 Issue:1 Volume:10 Page:20-33
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Yang Chang¹²,Jiang Yu¹³,Hao Sai Heng⁴,Yan Xing Yi²³,Hong De Fei⁵,Naranmandura Hua¹²³⁶^ORCID

Affiliation:

1. Department of Hematology, the First Affiliated Hospital, and Department of Public Health, Zhejiang University School of Medicine, Hangzhou, China

2. Department of Toxicology, School of Medicine and Public Health, Zhejiang University, Hangzhou, China

3. Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China

4. College of Pharmaceutical Sciences, Inner Mongolia Medical University, Hohhot, China

5. Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China

6. Zhejiang University Cancer Center, Hangzhou, China

Abstract

In this review, we comprehensively discuss the current advances in the screening approaches of aptamers targeting cancer specific biomarkers and development of the aptamer–drug conjugate strategy.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2022/TB/D1TB02098F

Reference119 articles.

1. Cancer treatment and survivorship statistics, 2019

2. Polymeric drug delivery systems for localized cancer chemotherapy

3. Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma

4. Controlled drug delivery vehicles for cancer treatment and their performance

5. Polymer micro/nanocarrier-assisted synergistic chemohormonal therapy for prostate cancer

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Immunomodulatory Mesoporous Silica Nanoparticles for Inflammatory and Cancer Therapies;Biomolecules;2024-08-25

2. DNA aptamer targeting USE1 as a novel biomarker for lung cancer;2024-08-18

3. Advancements and Challenges in Aptamer-Based Therapeutics and Diagnostics Across Diverse Medical Domains: A Comprehensive Review;Jordan Journal of Pharmaceutical Sciences;2024-06-25

4. Revolutionizing biomedicine: Aptamer-based nanomaterials and nanodevices for therapeutic applications;Biotechnology Reports;2024-06

5. APTAMERS: NANOMATERIALS AS A POTENTIAL AGENT FOR ANTIVIRAL THERAPEUTIC DRUG DELIVERY DEVELOPMENT: A SYSTEMATIC LITERATURE REVIEW;International Journal of Applied Pharmaceutics;2024-01-07